| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 30,401,607 | 41,923,036 | 40,150,788 | | Cost of Revenue | 6,869,143 | 9,245,293 | 20,928,100 | | | Gross Profit | 23,532,464 | 32,677,743 | 19,222,688 | | | Operating Expenses | | Research Development |
-
| 1,709,801 |
-
| | Selling General and Administrative | 18,761,160 | 19,547,990 | 8,167,925 | | Non Recurring | 79,593 | 955,653 | 368,950 | | Others | 4,107,557 | 5,763,844 | 5,730,500 | | | | Total Operating Expenses |
-
| 27,977,287 |
-
| | | | Operating Income or Loss | 584,154 | 4,700,456 | 4,955,313 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,723,806 | 4,943,858 | 4,658,975 | | Earnings Before Interest And Taxes | 4,414,558 | 9,622,367 | 9,981,275 | | Interest Expense | 4,605,012 | 5,680,050 | 5,106,425 | | Income Before Tax | (190,454) | 3,942,318 | 4,874,850 | | Income Tax Expense | (75,329) | 474,834 | (902,750) | | Minority Interest |
-
|
-
| (3,925) | | | | Net Income From Continuing Ops | (115,125) | 3,467,484 | 5,479,300 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (115,125) | 3,467,484 | 5,479,300 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($115,125) | $3,467,484 | $5,479,300 |
|
0.51% Nasdaq 
Income Statement
